Clinical trials: BMI/Body Composition

Healthy

A Study of LY3549492 in Healthy Weight Adult Participants

• Terminated
• Age: 55 to 80 years
• Phase 2
• Results posted

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2).

Trial name

NCT07085468

Testing

LY3549492

Where

21 sites in United States, Canada

Volunteers

1 people

Sponsor

Eli Lilly and Company